ClinicalTrials.gg
CompletedNCT05605340Her HOMEUpdated Nov 4, 2026Results posted

Healthier At-home Meals for Expectant Mothers

An interventional study of Meal Delivery in Pregnancy Related and Weight Gain, Maternal, sponsored by University of Alabama at Birmingham. Completed at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-04.

Sponsored by University of Alabama at Birmingham · Not applicable, Interventional, and Prevention

How we know

Updated Nov 4, 2026Now CompletedResults posted+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 61 studies in Gestational Weight Gain with a site in United States — 12 open to participants now, 15 under way, none of them phase 3. Gestational Weight Gain · United States.

Enrollment
42nd of 55
35 · median 70
Started
2023
with 9 others
No phase
53 of 61
11 open now
Registered
45th of 61
by date
Lead sponsor
5 of 61
University of Alabama at Birmingham

Among the 61 studies in Gestational Weight Gain with a site in United States, this one is the 42nd largest by enrollment of the 55 interventional ones that give a count, is one of 10 that started in 2023, is one of 53 with no phase, and was the 45th registered.

Gestational Weight Gain

135 studies on the registry are indexed under Gestational Weight Gain; 24 are open to participants now.

Browse Gestational Weight Gain studies →

Open to participants now

12 of the 61 studies in Gestational Weight Gain with a site in United States are open now. Recruiting first, the newest first:

7 more — sign in →

All 12 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 21 Gestational Weight Gain studies recruiting now, 7 (33%) set no upper age limit and 14 (67%) stop at 75 or younger; 4 take children under 18; 12 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 61 studies in Gestational Weight Gain with a site in United States, or all of them as a file.
02

Study summary

This study is being done to test the feasibility, acceptability, and preliminary efficacy of a meal delivery intervention for managing gestational weight gain among pregnant women with overweight or obesity.

03

Conditions studied

  • Pregnancy Related
  • Weight Gain, Maternal

Keywords

  • Maternal Overweight
  • Maternal Obesity
  • Gestational weight gain
  • Meal delivery
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥ 18 years
  • Gestational age ≤ 15 weeks as assessed by ultrasound
  • (BMI) ≥ 25 kg/m2
  • Singleton viable pregnancy
  • Receiving care and planning to deliver at UAB
  • Residing within the delivery radius of the meal delivery company
  • Wi-Fi or Bluetooth Internet connection in home (for digital Wi-Fi enabled study scale)

Exclusion criteria

Exclusion Criteria:

  • Self-reported major health conditions (e.g., heart disease, cancer, renal disease, and Type 1 or Type 2 diabetes)
  • Current substance abuse
  • Current treatment for serious psychiatric disorder (schizophrenia, bipolar disorder)
  • Known fetal anomaly
  • Planned termination of pregnancy
  • Past history or current diagnosis of anorexia or bulimia
  • Current use of one or more of the following medications:
  • Metformin
  • Systemic
  • Antipsychotic agents
  • Anti-seizure medications or mood stabilizers that would be expected to have a significant impact on body weight
  • Medications for ADHD including amphetamines and methylphenidate
  • Any teratogenic agent Class D
  • Participation in another dietary and/or weight management intervention during pregnancy
  • Unwilling or unable to consume prepared meals delivered weekly
  • Unable to understand and communicate in verbal and written English
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
35 participants (actual)

Study arms

  • Experimental
    Intervention

    Meal delivery intervention with brief behavioral support.

    Behavioral: Meal Delivery

Interventions

  • BehavioralMeal Delivery

    10 healthy, home-delivered meals per week + brief weekly remote behavioral support

06

What researchers measure

Primary outcomes

  1. Change in Weight From First to Last Prenatal Visit

    Weight measured at the first and last prenatal visits will be retrieved from medical records for all participants and used to calculate total weight change from the first to the last prenatal visit (i.e., gestational weight gain).

    Time frame: First prenatal visit (<=15 weeks gestation), last prenatal visit (35+ weeks gestation)

Secondary outcomes

  1. Change in Food Insecurity

    Determined using the 18-item United States (US) Household Food Security Survey Module based on the previous 30 days. Adult food security scores range from 0 to 10, with lower values indicating greater food security. Change in Food Security was calculated as food security score at follow up minus score at baseline, with negative values indicating an increase in food security from baseline to follow up.

    Time frame: baseline (12-15 weeks gestation), (35-36 weeks gestation)

  2. Change in Perceived Stress

    Determined using the 10-item Perceived Stress Scale (PSS-10) based on the last month. PSS-10 scores range from 0 to 40, with higher scores representing higher levels of perceived stress. Change in Perceived Stress score was calculated as score at follow up minus score at baseline, with positive values indicating an increase in perceived stress score from baseline to follow up.

    Time frame: baseline (12-15 weeks gestation), (35-36 weeks gestation)

  3. Change in Participant Satisfaction With Diet

    To assess satisfaction with the study intervention, the 28-item Diet Satisfaction Questionnaire (DSAT-28) will be used in which participants respond to 28 statements using a 5-point Likert scale. Responses to all 28-items are averaged to produce a total diet satisfaction score (designed to reflect satisfaction as it relates to following a weight-management diet) ranging from 1-5. Subscale scores for Cost Factor (reflects financial cost of the diet) and Planning \& Preparation Factor (reflects amount of time and effort spent in planning and preparing) will also be calculated and range from 1-5. For the overall diet satisfaction score and subscale scores, higher scores represent greater satisfaction. Changes in overall diet satisfaction, as well as changes in subscale scores for Cost Factor and Planning \& Preparation Factor are calculated as score at follow up minus score at baseline, with positive values indicating an increase in satisfaction) from baseline to follow up.

    Time frame: baseline (12-15 weeks gestation), (35-36 weeks gestation)

  4. Proportion of Women Exceeding Institute of Medicine Gestational Weight Gain Guidelines

    Weight at the first prenatal visit will be subtracted from weight at the last prenatal visit. Women will be categorized as exceeding 2009 Institute of Medicine gestational weight gain guidelines if the difference is \> 11.5 kg gain for women with overweight or \>9 kg for women with obesity at the first prenatal visit.

    Time frame: First prenatal visit (<=15 weeks gestation), last prenatal visit (35+ weeks gestation)

07

Results

Posted Nov 4, 2026

Participant flow

Participant flow — Overall Study
MilestoneMeal Delivery Intervention
Started35
Completed34
Not completed1
Withdrew: Participant relocated out of country1

Outcome measures

PrimaryChange in Weight From First to Last Prenatal Visit

Weight measured at the first and last prenatal visits will be retrieved from medical records for all participants and used to calculate total weight change from the first to the last prenatal visit (i.e., gestational weight gain).

Time frame:
First prenatal visit (<=15 weeks gestation), last prenatal visit (35+ weeks gestation)
Reported as:
Mean · pounds
Change in Weight From First to Last Prenatal Visit
poundsMeal Delivery Intervention
Change in Weight From First to Last Prenatal Visit28.3 ± 15.7
SecondaryChange in Food Insecurity

Determined using the 18-item United States (US) Household Food Security Survey Module based on the previous 30 days. Adult food security scores range from 0 to 10, with lower values indicating greater food security. Change in Food Security was calculated as food security score at follow up minus score at baseline, with negative values indicating an increase in food security from baseline to follow up.

Time frame:
baseline (12-15 weeks gestation), (35-36 weeks gestation)
Reported as:
Mean · score on a scale
Change in Food Insecurity
score on a scaleMeal Delivery Intervention
Change in Food Insecurity-0.2 ± 0.6
SecondaryChange in Perceived Stress

Determined using the 10-item Perceived Stress Scale (PSS-10) based on the last month. PSS-10 scores range from 0 to 40, with higher scores representing higher levels of perceived stress. Change in Perceived Stress score was calculated as score at follow up minus score at baseline, with positive values indicating an increase in perceived stress score from baseline to follow up.

Time frame:
baseline (12-15 weeks gestation), (35-36 weeks gestation)
Reported as:
Mean · score on a scale
Change in Perceived Stress
score on a scaleMeal Delivery Intervention
Change in Perceived Stress-0.03 ± 5.5
SecondaryChange in Participant Satisfaction With Diet

To assess satisfaction with the study intervention, the 28-item Diet Satisfaction Questionnaire (DSAT-28) will be used in which participants respond to 28 statements using a 5-point Likert scale. Responses to all 28-items are averaged to produce a total diet satisfaction score (designed to reflect satisfaction as it relates to following a weight-management diet) ranging from 1-5. Subscale scores for Cost Factor (reflects financial cost of the diet) and Planning \& Preparation Factor (reflects amount of time and effort spent in planning and preparing) will also be calculated and range from 1-5. For the overall diet satisfaction score and subscale scores, higher scores represent greater satisfaction. Changes in overall diet satisfaction, as well as changes in subscale scores for Cost Factor and Planning \& Preparation Factor are calculated as score at follow up minus score at baseline, with positive values indicating an increase in satisfaction) from baseline to follow up.

Time frame:
baseline (12-15 weeks gestation), (35-36 weeks gestation)
Reported as:
Mean · score on a scale
Change in Participant Satisfaction With Diet
score on a scaleMeal Delivery Intervention
Change in overall diet satisfaction score0.3 ± 0.5
Change in Cost Factor Score0.5 ± 0.9
Change in Planning & Preparation Factor Score0.4 ± 0.9
SecondaryProportion of Women Exceeding Institute of Medicine Gestational Weight Gain Guidelines

Weight at the first prenatal visit will be subtracted from weight at the last prenatal visit. Women will be categorized as exceeding 2009 Institute of Medicine gestational weight gain guidelines if the difference is \> 11.5 kg gain for women with overweight or \>9 kg for women with obesity at the first prenatal visit.

Time frame:
First prenatal visit (<=15 weeks gestation), last prenatal visit (35+ weeks gestation)
Reported as:
Count of participants · Participants
Proportion of Women Exceeding Institute of Medicine Gestational Weight Gain Guidelines
ParticipantsMeal Delivery Intervention
Exceeded Institute of Medicine Gestational Weight Gain Guidelines20
Did Not Exceed Institute of Medicine Gestational Weight Gain Guidelines14

Adverse events

Collected over From enrollment until end of meal delivery intervention at 40 weeks gestation, up to 27 weeks. Adverse event data were collected via weekly electronic surveys sent each week during the intervention.. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Meal Delivery Intervention0/35 (0%)6/35 (17.1%)7/35 (20%)
Most frequent serious events
Most frequent serious events
EventMeal Delivery Intervention
PreeclampsiaPregnancy, puerperium and perinatal conditions2/35
Idiopathic cranial hypertensionNervous system disorders1/35
Emergency cesarean sectionPregnancy, puerperium and perinatal conditions1/35
Fetal atrial flutterPregnancy, puerperium and perinatal conditions1/35
MiscarriagePregnancy, puerperium and perinatal conditions1/35
Most frequent other events
Most frequent other events
EventMeal Delivery Intervention
Nausea, emesis, or diarrheaGastrointestinal disorders4/35
New or worsening gastroesophageal reflux (GERD)Gastrointestinal disorders3/35

Baseline characteristics

Not applicable- no differences between these numbers and the number of participants assigned in the Participant Flow.

Age, Categorical
Age, Categorical(Participants)Meal Delivery Intervention
<=18 years1
Between 18 and 65 years34
>=65 years0
Age, Continuous
Age, Continuous(years)Meal Delivery Intervention
Mean31.4 ± 5.4
Sex: Female, Male
Sex: Female, Male(Participants)Meal Delivery Intervention
Female35
Male0
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Meal Delivery Intervention
American Indian or Alaska Native0
Asian1
Native Hawaiian or Other Pacific Islander0
Black or African American16
White16
More than one race0
Unknown or Not Reported2
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Meal Delivery Intervention
Hispanic or Latino4
Not Hispanic or Latino31
Unknown or Not Reported0
Gestational age at baseline
Gestational age at baseline(weeks)Meal Delivery Intervention
Mean13.6 ± 0.6
08

Study locations

1 site
  • University of Alabama at Birmingham
    Birmingham, Alabama 35294, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — De-identified individual participant data (IPD) that underlie the results reported in a publication will be made available upon request beginning 9 months and ending 36 months following article publication. The research team will keep a record of all individuals and/or research teams who request and receive a copy of the project data. Interested investigators will be asked to submit a document indicating the specific aims of the analyses, the analytic plan, available resources for completing the proposed project, proposed timeline, and goals (i.e., manuscripts, presentations, and/or grant applications). The PI and research team will review these requests to determine whether the proposed analyses constitute an innovative and significant exploration of the data, whether the proposed team has sufficient resources to complete the request, and whether data will be adequately protected and managed.

Supporting information: Study protocol, Informed consent form

Time frame: Data requests can be submitted starting 9 months after publication of results and ending 36 months following article publication.

Access criteria: Access to IPD stripped of all HIPAA identifiers (except age) for this study can be requested by qualified researchers engaging in independent scientific research whose proposed research has received Institutional Review Board approval, and will be provided following review and approval of a research proposal and timeline, statistical analysis plan, and goals (e.g., manuscripts, presentations, grant applications). The Principal Investigator (PI) and research team will review these requests to determine whether the proposed analyses constitute an innovative and significant exploration of the data, whether the proposed team has sufficient resources to complete the request, and whether data will be adequately protected and managed. Based on institutional policies, execution of a Data Sharing Agreement may be required prior to sharing of IPD. IPD requests can be made to the MPIs at gdutton@uabmc.edu or cschneid@uab.edu.

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2023 to primary completion in Oct 2025, 26 months.

Results were first posted in Nov 2026, 1 year after primary completion.

Of 84 non-industry interventional studies with no phase under Gestational Weight Gain, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 38. This study's 26 months is close to that.

Counting every sponsor, half of 84 studies reached it within 24 months; a quarter within 13 and three quarters within 38.

Completion moved once since we started tracking on Sep 25, 2026: Oct 2026 → Oct 2025, on Nov 4, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Oct 25, 2022
First posted
Nov 4, 2022
StartActual
Aug 9, 2023
Primary completionActual
Oct 14, 2025
CompletionActual
Oct 31, 2025was Oct 2026
Results first posted
Nov 4, 2026
Last update
Nov 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Completed
changed Nov 4, 2026
Results
Results posted
posted Nov 4, 2026
Study completion
Oct 31, 2026→Oct 31, 2025 (actual)
Nov 4, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • EditedChange in weight from firstWeight From First to last prenatal visitLast Prenatal VisitTime frame: First prenatal visit (<15 weeks gestation), last prenatal visit (35+ weeks gestation) → First prenatal visit (<=15 weeks gestation), last prenatal visit (35+ weeks gestation)
Nov 4, 2026
Secondary outcomes
1 edited, 1 time frame changed, 2 description edited
What changed in the outcomes
  • EditedChange in Participant Satisfaction withWith DietTime frame: baseline (12-15 weeks gestation), (35-36 weeks gestation)
  • Time frameProportion of Women Exceeding Institute of Medicine Gestational Weight Gain GuidelinesFirst prenatal visit (<15 weeks gestation), last prenatal visit (35+ weeks gestation) → First prenatal visit (<=15 weeks gestation), last prenatal visit (35+ weeks gestation)
  • DescriptionChange in Food Insecurity: how it is measured was reworded
  • DescriptionChange in Perceived Stress: how it is measured was reworded
Nov 4, 2026
Show all 1 update
  1. Nov 4, 2026
    Active, not recruiting→Completed
    Results posted
    Study completion Oct 31, 2026→Oct 31, 2025 (now actual)
    Primary outcomes 1 edited
    What changed in the outcomes
    • EditedChange in weight from firstWeight From First to last prenatal visitLast Prenatal VisitTime frame: First prenatal visit (<15 weeks gestation), last prenatal visit (35+ weeks gestation) → First prenatal visit (<=15 weeks gestation), last prenatal visit (35+ weeks gestation)
    Secondary outcomes 1 edited, 1 time frame changed, 2 description edited
    What changed in the outcomes
    • EditedChange in Participant Satisfaction withWith DietTime frame: baseline (12-15 weeks gestation), (35-36 weeks gestation)
    • Time frameProportion of Women Exceeding Institute of Medicine Gestational Weight Gain GuidelinesFirst prenatal visit (<15 weeks gestation), last prenatal visit (35+ weeks gestation) → First prenatal visit (<=15 weeks gestation), last prenatal visit (35+ weeks gestation)
    • DescriptionChange in Food Insecurity: how it is measured was reworded
    • DescriptionChange in Perceived Stress: how it is measured was reworded
    + 2 other changes: verification date and responsible party

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT05605340
Responsible party
Gareth R. Dutton PhD (Primary Investigator, University of Alabama at Birmingham) — Principal investigator
First posted
Nov 4, 2022
Start date
Aug 9, 2023
Primary completion
Oct 14, 2025
Completion
Oct 31, 2025
Results posted
Nov 4, 2026
Last update
Nov 4, 2026

Study contacts

Gareth Dutton, PhD
principal investigator · University of Alabama at Birmingham
Camille Worthington, PhD
principal investigator · University of Alabama at Birmingham

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion